共 22 条
- [1] Janjigian YY(2021)First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial Lancet 398 27-40
- [2] Shitara K(2022)Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Lancet Oncol 23 234-247
- [3] Moehler M(2020)Clinical case of the neoadjuvant treatment with nivolumab in a patient with microsatellite unstable (MSI-H) locally advanced gastric cancer BMJ Case Rep 13 179-undefined
- [4] Garrido M(2020)Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report World J Surg Oncol 18 undefined-undefined
- [5] Salman P(undefined)undefined undefined undefined undefined-undefined
- [6] Shen L(undefined)undefined undefined undefined undefined-undefined
- [7] Kang Y-K(undefined)undefined undefined undefined undefined-undefined
- [8] Chen L-T(undefined)undefined undefined undefined undefined-undefined
- [9] Ryu M-H(undefined)undefined undefined undefined undefined-undefined
- [10] Oh D-Y(undefined)undefined undefined undefined undefined-undefined